hrp0097p1-62 | Fat, Metabolism and Obesity | ESPE2023

Effect of metreleptin on metabolic changes in patient with congenital generalized lipodystrophy

Rakhimzhanova Marzhan , Issabayeva Assel , Umerzakova Aigerim , Alzhaxina Alina

Background: Congenital generalized lipodystrophy is a rare and serious genetic disorder that has a profound impact on the quality of life of individuals. The worldwide prevalence of disease is estimated at 1 in 12 million people. It causes significant metabolic abnormalities and may reduce the life expectancy of children and young adults due to the late diagnosis and absence of adequate treatment. Below, we report the case of an 8-year-old boy with Berardinell...